Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
ClinicalTrials.gov study NCT00206388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov study NCT00074139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT03099356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
ClinicalTrials.gov study NCT01995331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT02206503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide in Lupus Nephritis
ClinicalTrials.gov study NCT00441220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
ClinicalTrials.gov study NCT01677949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
ClinicalTrials.gov study NCT00398489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT
ClinicalTrials.gov study NCT02812940. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBC
ClinicalTrials.gov study NCT02772822. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
ClinicalTrials.gov study NCT04959175. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT02204241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
ClinicalTrials.gov study NCT03139851. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00397800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
ClinicalTrials.gov study NCT00379015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT06041893. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
ClinicalTrials.gov study NCT02399358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00017628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide
ClinicalTrials.gov study NCT06361264. IPD Sharing: NO. Countries: 1. Publications: 0.
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic H
ClinicalTrials.gov study NCT02342613. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.